Tetralogic Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Tetralogic Pharmaceuticals's estimated annual revenue is currently $1.9M per year.
- Tetralogic Pharmaceuticals's estimated revenue per employee is $169,091
Employee Data
- Tetralogic Pharmaceuticals has 11 Employees.
- Tetralogic Pharmaceuticals grew their employee count by 10% last year.
Tetralogic Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|
Tetralogic Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.6M | 7 | -12% | N/A | N/A |
#2 | $4M | 38 | 81% | N/A | N/A |
#3 | N/A | 76 | 27% | N/A | N/A |
#4 | $0.9M | 5 | 0% | N/A | N/A |
#5 | $1.1M | 8 | 33% | N/A | N/A |
#6 | $10.9M | 61 | 7% | N/A | N/A |
#7 | $0.7M | 9 | 29% | N/A | N/A |
#8 | $4M | 20 | -5% | N/A | N/A |
#9 | $1.7M | 11 | 22% | N/A | N/A |
#10 | $7.6M | 49 | 2% | N/A | N/A |
What Is Tetralogic Pharmaceuticals?
TetraLogic Pharmaceuticals (Nasdaq: TLOG) is a clinical-stage biopharmaceutical company focused on discovering, acquiring and developing novel product candidates to treat cancer and infectious diseases. We currently have two clinical-stage product candidates in development: birinapant and suberohydroxamic acid (4-methoxycarbonyl) phenyl ester (SHAPE).
keywords:N/A
N/A
Total Funding
11
Number of Employees
$1.9M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Malvern
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 11 | N/A | N/A |
#2 | $1M | 11 | 0% | N/A |
#3 | $3.3M | 12 | -29% | N/A |
#4 | $1.5M | 12 | N/A | N/A |
#5 | $1.8M | 13 | 8% | N/A |